CompletedPHASE1, PHASE2NCT00272844
Treatment of the Cholesterol Defect in Smith-Lemli-Opitz Syndrome
Studying 46,XY difference of sex development due to a cholesterol synthesis defect
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Boston Children's Hospital
- Principal Investigator
- Mira Irons, M.D.Boston Children's Hospital
- Intervention
- crystalline cholesterol oil-based suspension(drug)
- Enrollment
- 23 enrolled
- Eligibility
- All sexes
- Timeline
- 1998 – 2011
Study locations (1)
- Children's Hospital Boston, Boston, Massachusetts, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00272844 on ClinicalTrials.gov